¼¼°èÀÇ ¾ÆÇÇ°Ô´Ñ ½ÃÀå
Apigenin
»óǰÄÚµå : 1791479
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License)
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)


Çѱ۸ñÂ÷

¼¼°èÀÇ ¾ÆÇÇ°Ô´Ñ ½ÃÀåÀº 2030³â±îÁö 35¸¸ 9,500´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 31¸¸ 3,600´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¾ÆÇÇ°Ô´Ñ ½ÃÀåÀº 2030³â¿¡´Â 35¸¸ 9,500´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 2.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ 0.95 ¼øµµ ·¹º§Àº CAGR 2.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 20¸¸ 9,400´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 0.98 ¼øµµ ·¹º§ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 1.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8¸¸ 5,400´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¾ÆÇÇ°Ô´Ñ ½ÃÀåÀº 2024³â¿¡ 8¸¸ 5,400´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¸¸ 8,700´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 4.5%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 0.8%¿Í 1.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¾ÆÇÇ°Ô´Ñ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾ÆÇÇÁ¦´ÑÀÌ ´Ù¾çÇÑ »ê¾÷¿¡¼­ ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¾ÆÇÇÁ¦´ÑÀº Ä«¸ð¸¶ÀÏ, ÆÄ½½¸®, ¼¿·¯¸®, °¨±Ö·ù µî ´Ù¾çÇÑ ½Ä¹°¿¡ ÇÔÀ¯µÈ õ¿¬ À¯·¡ Çö󺸳ëÀ̵åÀ̸ç, ÀǾàǰ, °Ç°­±â´É½Äǰ, È­Àåǰ, ±â´É¼º ½Äǰ »ê¾÷¿¡ ÀÀ¿ëµÇ¾î ³Î¸® ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ ¼±È£µµ°¡ ½Ä¹° À¯·¡ÀÇ »ý¸®È°¼º È­ÇÕ¹°·Î À̵¿ÇÏ´Â °¡¿îµ¥, ¾ÆÇÇÁ¦´ÑÀº ÀáÀçÀûÀÎ °Ç°­ ÁõÁø Ư¼º°ú °úÇÐÀû °ËÁõÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¸Å¿ì Àαâ ÀÖ´Â ¼ººÐÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Á¦¾à ºÐ¾ß¿¡¼­ ½Ä¹° ÃßÃâ¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¾ÆÇÇÁ¦´ÑÀº Á¾¾çÇÐ, ½ÉÇ÷°ü °Ç°­, ½Å°æ º¸È£¿¡ ´ëÇÑ °¡´É¼ºÀ» °ËÅäÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, ±â´É¼º ½Äǰ ¹× °Ç°­º¸Á¶½Äǰ ¾÷°è¿¡¼­´Â °Ç°­ ÁõÁø°ú Àå¼ö¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â °Ç°­º¸Á¶½ÄǰÀÇ ÁÖ¿ä ¼ººÐÀ¸·Î ¾ÆÇÇÁ¦´ÑÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å¬¸° ºäƼ ¿îµ¿Àº ½ºÅ² ÄÉ¾î ¹× ÆÛ½º³ÎÄɾî Á¦Á¦¿¡¼­ÀÇ »ç¿ëÀ» ´õ¿í ÃËÁøÇÏ¿© ³ëÈ­ ¹æÁö Å©¸², ¼¼·³, Àڿܼ± Â÷´Ü Á¦Á¦¿¡ ÅëÇյǾî ÀÖ½À´Ï´Ù. õ¿¬ ¹× ½Ä¹°¼º ¼ººÐ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¾ÆÇÇÁ¦´ÑÀÇ Á¸Àç°¨ÀÌ °­È­µÇ°í ÀÖÀ¸¸ç, Àüü·ÐÀû °Ç°­ ¹× À£ºù ¼Ö·ç¼ÇÀÇ Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ¾î¶»°Ô ¾ÆÇÇÁ¦´ÑÀÇ ÃßÃâ°ú Á¦ÇüÈ­¸¦ °­È­Çϴ°¡?

ÃßÃâ ±â¼ú°ú Á¦Çü ±â¼úÀÇ ¹ßÀüÀº ¾ÆÇÇÁ¦´ÑÀÇ »ê¾÷Àû ÀÀ¿ë¿¡¼­ »ó¾÷Àû ½ÇÇà °¡´É¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀüÅëÀûÀÎ ¿ë¸Å ÃßÃâ ¹æ¹ýÀº ÇöÀç ÃÊÀÓ°è À¯Ã¼ ÃßÃâ, ÃÊÀ½ÆÄ º¸Á¶ ÃßÃâ(UAE), È¿¼Ò °¡¼öºÐÇØ¿Í °°Àº º¸´Ù È¿À²ÀûÀÎ Á¢±Ù¹ýÀ¸·Î º¸¿ÏµÇ¾î ¼öÀ², ¼øµµ ¹× »ýü ÀÌ¿ë·üÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸®Æ÷Á», °íºÐÀÚ ³ª³ëÀÔÀÚ Àü´Þ ½Ã½ºÅÛ µî ³ª³ëÅ×Å©³î·¯Áö°ú ÀÎĸ½¶·¹ÀÌ¼Ç ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀǾàǰ ¹× È­Àåǰ Á¦Á¦¿¡¼­ ¾ÆÇÇÁ¦´ÑÀÇ ¾ÈÁ¤¼º°ú Èí¼ö¼ºÀÌ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ¾ÆÇÇÁ¦´ÑÀ» ±â¹ÝÀ¸·Î ÇÑ »ý¹°ÇÐÀû È¿´ÉÀÌ Çâ»óµÇ°í, ¹æÃâÀÌ Á¶ÀýµÈ Á¦Ç° °³¹ßÀÌ °¡´ÉÇØÁ® ´Ù¾çÇÑ ºÐ¾ß·ÎÀÇ Àû¿ëÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ AI¸¦ Ȱ¿ëÇÑ Á¦ÇüÈ­ ±â¼úÀ» ÅëÇØ Á¦Á¶¾÷ü´Â ¾ÆÇÇÁ¦´Ñ ±â¹Ý È­ÇÕ¹°À» Ÿ°ÙÀ¸·Î ÇÑ Ä¡·á ¿ëµµ¿¡ ÃÖÀûÈ­ÇÏ¿© Á¦Á¶ ºñ¿ëÀ» Àý°¨Çϰí È®À强À» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. »ý¸í°øÇÐ, ƯÈ÷ ¹Ì»ý¹°¿¡ ÀÇÇÑ »ýÇÕ¼ºÀÇ ÅëÇÕÀº ¾ÆÇÇÁ¦´ÑÀÇ Áö¼Ó°¡´ÉÇÏ°í ¾ÈÁ¤ÀûÀÎ »ý»êÀÇ ±æÀ» ¿­¾î °èÀýÀû ½Ä¹° °ø±Þ¿ø¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀÌ°í °ø±Þ¸ÁÀÇ Åº·Â¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ÃßÃâ È¿À²°ú Á¦Á¦ÀÇ ¾ÈÁ¤¼ºÀÌ Çâ»óµÊ¿¡ µû¶ó ¾ÆÇÇÁ¦´ÑÀº °Ç°­ ¹× À£ºù »ê¾÷¿¡¼­ »ý¸®È°¼º È­ÇÕ¹°ÀÇ ÁÖ·ù°¡ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾î¶² ½ÃÀå µ¿ÇâÀÌ ¾ÆÇÇÁ¦´Ñ ±â¹Ý Á¦Ç° ¼ö¿ä¸¦ ÁÖµµÇϰí Àִ°¡?

¸î °¡Áö Áß¿äÇÑ ½ÃÀå µ¿Çâ, ƯÈ÷ °Ç°­ º¸Á¶ ½Äǰ, Á¦¾à ¹× ÆÛ½º³ÎÄÉ¾î »ê¾÷¿¡¼­ ¾ÆÇÇÁ¦´Ñ ±â¹Ý Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. õ¿¬ ¹× À¯±â³ó ¼ººÐ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½Ä¹° À¯·¡ »ý¸®È°¼º ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¾ÆÇÇÁ¦´ÑÀº °Ç°­±â´É½Äǰ ¹× ±â´É¼º ½Äǰ¿¡¼­ ÇÕ¼º È­ÇÕ¹°À» ´ëüÇÒ ¼ö ÀÖ´Â ¿ø·á·Î ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ÇâÁ¤½Å¼º ÀǾàǰ°ú ÀÎÁö ±â´É Çâ»ó º¸ÃæÁ¦ÀÇ ÀαⰡ ³ô¾ÆÁö¸é¼­ ¾ÆÇÇÁ¦´Ñ¿¡ ´ëÇÑ °ü½ÉÀÌ ´õ¿í ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ÀÎÁö °Ç°­ ¹× ½Å°æ º¸È£¿¡ ´ëÇÑ ¿ªÇÒÀ» Áö¿øÇÏ´Â ¿¬±¸ °á°úµµ ³ª¿À°í ÀÖ½À´Ï´Ù. ÇÑÆí, ½ºÅ²ÄÉ¾î ¾÷°è¿¡¼­´Â ½Ä¹° À¯·¡ ¼ººÐÀ¸·ÎÀÇ ÀüȯÀÌ ÀϾ°í ÀÖÀ¸¸ç, ¾ÆÇÇÁ¦´ÑÀ» ¾ÈƼ¿¡ÀÌ¡, Ç×»êÈ­, Ç׿°Áõ ½ºÅ²Äɾî Á¦Á¦¿¡ µµÀÔÇÏ´Â ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ¿µ¾çÇаú Á¤¹ÐÀÇ·áÀÇ ºÎ»óµµ ¾ÆÇÇÁ¦´Ñ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, °úÇÐÀû ¿¬±¸¸¦ ÅëÇØ ¾ÆÇÇÁ¦´ÑÀÇ Ç¥ÀûÈ­µÈ °Ç°­ ÀÀ¿ë¿¡ ´ëÇÑ ¾ÆÇÇÁ¦´ÑÀÇ ¿ªÇÒÀÌ Á¡Â÷ ¹àÇôÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â´É¼º ½Äǰ ¹× ÀǾàǰ¿¡ õ¿¬ À¯·¡ Çö󺸳ëÀ̵åÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â ±ÔÁ¦ º¯È­µµ ¾ÆÇÇÁ¦´Ñ ±â¹Ý Á¦Ç° ½ÃÀå ÁøÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. E-Commerce¿Í DTC(Direct-to-Consumer) À£´Ï½º ºê·£µåÀÇ È®»êÀº ¾ÆÇÇÁ¦´ÑÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓÈ­ÇÏ¿© Àü ¼¼°è °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀڵ鿡°Ô ´õ¿í Ä£¼÷ÇÏ°Ô ´Ù°¡°¥ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¾ÆÇÇÁ¦´ÑÀÌ ¿©·¯ ¼ÒºñÀÚ ÁÖµµÇü »ê¾÷¿¡¼­ Å« ¼ºÀåÀ» ÀÌ·ç¸ç Áö¼ÓÀûÀÎ ½ÃÀå ¼ºÀåÀ» ÀÌ·ê °ÍÀÓÀ» º¸¿©ÁÝ´Ï´Ù.

¾ÆÇÇÁ¦´Ñ ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¾ÆÇÇÁ¦´Ñ ½ÃÀåÀÇ ¼ºÀåÀº ÃßÃâ ¹× Á¦Çü ±â¼úÀÇ ¹ßÀü, ½Ä¹° À¯·¡ º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡, ÀǾàǰ, °Ç°­º¸Á¶½Äǰ, È­Àåǰ¿¡ ´ëÇÑ Àû¿ë ¹üÀ§ È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¾ÆÇÇÁ¦´ÑÀÇ Ä¡·á °¡´É¼ºÀ» Áö¿øÇÏ´Â ÀÓ»ó ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¦¾àȸ»çµéÀº ÀÌ »ý¸®È°¼º Çö󺸳ëÀ̵带 Æ÷ÇÔÇÏ´Â »õ·Î¿î ¾à¹° Á¦Á¦¸¦ °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç µîÀÇ Áö¿ª¿¡¼­ ±â´É¼º ½Äǰ ¹× À½·á »ê¾÷ÀÌ È®´ëµÇ¸é¼­ ¸é¿ª Áö¿ø, ÀÎÁö ±â´É, ½ÅÁø´ë»ç °Ç°­À» À§ÇÑ ¾ÆÇÇÁ¦´Ñ °­È­ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ºÅ²ÄÉ¾î ºÐ¾ßÀÇ Å¬¸° ºäƼ ¿îµ¿°ú Áö¼Ó°¡´É¼º Áß½ÉÀÇ Çõ½ÅÀÌ È­Àåǰ Á¦Çü¿¡ ¾ÆÇÇÁ¦´ÑÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. Çö󺸳ëÀÌµå ±â¹Ý ±â´É¼º ¼ººÐ¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ Áõ°¡´Â ¼¼°è ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖÀ¸¸ç, ±â¾÷Àº ÁøÈ­ÇÏ´Â ¼ÒºñÀÚÀÇ ±â´ë¿¡ ºÎÀÀÇϱâ À§ÇØ ±ÔÁ¤ Áؼö, ¾ÈÀü¼º, È¿´É¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù. µðÁöÅÐ °Ç°­ Ç÷§Æû°ú °³ÀÎÈ­µÈ À£´Ï½º ¼Ö·ç¼ÇÀÇ ºü¸¥ ¼ºÀåµµ ½ÃÀå µ¿ÇâÀ» Çü¼ºÇϰí ÀÖÀ¸¸ç, ¼ÒºñÀÚµéÀº ƯÁ¤ °Ç°­ ¿ä±¸¿¡ ¸Â´Â ¾ÆÇÇÁ¦´Ñ ±â¹Ý Á¦Ç°¿¡ Á¢±ÙÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å, »ê¾÷ ¿ëµµ È®´ë, ¼ÒºñÀÚ ¼±È£µµ ÁøÈ­·Î ÀÎÇØ ¾ÆÇÇÁ¦´Ñ ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î È®´ëµÇ°í ÀÖÀ¸¸ç ¿©·¯ ºÐ¾ßÀÇ Á¦Á¶¾÷ü¿Í ÀÌÇØ °ü°èÀÚ¿¡°Ô »õ·Î¿î ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

ºÎ¹®

À¯Çü(0.95 ¼øµµ ·¹º§, 0.98 ¼øµµ ·¹º§, ±âŸ À¯Çü), ¿ëµµ(ÀǾàǰ¡¤ÇコÄÉ¾î ¿ëµµ, ½Äǰ÷°¡Á¦ ¿ëµµ, È­Àåǰ¡¤½ºÅ²ÄÉ¾î ¿ëµµ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Apigenin Market to Reach US$359.5 Thousand by 2030

The global market for Apigenin estimated at US$313.6 Thousand in the year 2024, is expected to reach US$359.5 Thousand by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. 0.95 Purity Level, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$209.4 Thousand by the end of the analysis period. Growth in the 0.98 Purity Level segment is estimated at 1.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.4 Thousand While China is Forecast to Grow at 4.5% CAGR

The Apigenin market in the U.S. is estimated at US$85.4 Thousand in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$68.7 Thousand by the year 2030 trailing a CAGR of 4.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Apigenin Market - Key Trends & Drivers Summarized

Why Is Apigenin Gaining Prominence Across Diverse Industries?

Apigenin, a naturally occurring flavonoid found in various plant sources such as chamomile, parsley, celery, and citrus fruits, is gaining widespread attention for its applications across pharmaceuticals, nutraceuticals, cosmetics, and functional food industries. As consumer preferences shift toward plant-derived bioactive compounds, apigenin is emerging as a highly sought-after ingredient due to its potential health-promoting properties and increasing scientific validation. The demand for botanical extracts in the pharmaceutical sector has surged, with apigenin being explored for its potential in oncology, cardiovascular health, and neuroprotection. Meanwhile, the functional food and nutraceutical industry has embraced apigenin as a key ingredient in dietary supplements aimed at promoting overall wellness and longevity. Additionally, the clean beauty movement has further propelled its use in skincare and personal care formulations, where it is being integrated into anti-aging creams, serums, and UV-protection formulations. The expanding consumer awareness regarding natural and plant-based ingredients is reinforcing the prominence of apigenin, positioning it as a crucial component in holistic health and wellness solutions.

How Are Technological Innovations Enhancing Apigenin Extraction and Formulation?

The advancement of extraction technologies and formulation techniques has played a pivotal role in improving the commercial viability of apigenin for industrial applications. Traditional solvent extraction methods are now being supplemented with more efficient approaches such as supercritical fluid extraction, ultrasound-assisted extraction (UAE), and enzymatic hydrolysis, which enhance yield, purity, and bioavailability. Furthermore, advancements in nanotechnology and encapsulation techniques, such as liposomal and polymeric nanoparticle delivery systems, have significantly improved the stability and absorption of apigenin in both pharmaceutical and cosmetic formulations. These innovations have made it possible to develop apigenin-based products with enhanced bioefficacy and controlled-release mechanisms, increasing its applicability across multiple sectors. Additionally, AI-driven formulation techniques are enabling manufacturers to optimize apigenin-based compounds for targeted therapeutic applications, reducing production costs and improving scalability. The integration of biotechnology, particularly microbial biosynthesis, is also paving the way for sustainable and consistent production of apigenin, reducing dependence on seasonal plant sources and improving supply chain resilience. As technological advancements continue to enhance extraction efficiency and formulation stability, apigenin is set to become a mainstream bioactive compound in the health and wellness industry.

What Market Trends Are Driving the Demand for Apigenin-Based Products?

Several key market trends are shaping the demand for apigenin-based products, particularly in the nutraceutical, pharmaceutical, and personal care industries. The increasing consumer inclination toward natural and organic ingredients has led to a surge in demand for plant-derived bioactives, positioning apigenin as a preferred alternative to synthetic compounds in dietary supplements and functional foods. The growing popularity of nootropics and cognitive-enhancing supplements has further fueled interest in apigenin, with research supporting its role in cognitive health and neuroprotection. Meanwhile, the skincare industry is witnessing a shift towards botanically sourced ingredients, driving the incorporation of apigenin into anti-aging, antioxidant-rich, and anti-inflammatory skincare formulations. The rise of personalized nutrition and precision medicine has also contributed to the expansion of the apigenin market, as scientific research continues to uncover its role in targeted health applications. Additionally, regulatory shifts promoting the use of naturally occurring flavonoids in functional foods and pharmaceuticals have facilitated market entry for apigenin-based products. The increasing penetration of e-commerce and direct-to-consumer (DTC) wellness brands has further accelerated the adoption of apigenin, making it more accessible to health-conscious consumers worldwide. These evolving trends indicate a sustained market trajectory, with apigenin poised for significant growth across multiple consumer-driven industries.

What Are the Key Growth Drivers Fueling the Apigenin Market Expansion?

The growth in the apigenin market is driven by several factors, including advancements in extraction and formulation technologies, increasing consumer demand for botanical-based supplements, and the expanding application scope in pharmaceuticals, nutraceuticals, and cosmetics. The rising investment in clinical research supporting apigenin’s therapeutic potential is encouraging pharmaceutical companies to explore new drug formulations incorporating this bioactive flavonoid. The functional food and beverage industry’s expansion, particularly in regions such as North America, Europe, and Asia-Pacific, is contributing to higher demand for apigenin-enriched products targeting immune support, cognitive function, and metabolic health. Additionally, the clean beauty movement and sustainability-driven innovations in skincare are further accelerating apigenin’s adoption in cosmetic formulations. The increasing regulatory approvals for flavonoid-based functional ingredients are facilitating global market growth, prompting companies to focus on compliance, safety, and efficacy to meet evolving consumer expectations. The rapid growth of digital health platforms and personalized wellness solutions is also shaping market trends, allowing consumers to access apigenin-based products tailored to their specific health needs. With ongoing innovations, expanding industry applications, and evolving consumer preferences, the apigenin market is set for continuous expansion, offering new opportunities for manufacturers and stakeholders across multiple sectors.

SCOPE OF STUDY:

The report analyzes the Apigenin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (0.95 Purity Level, 0.98 Purity Level, Other Types): Application (Pharma & Healthcare Application, Food Additives Application, Cosmetic & Skin Care Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â